Loading clinical trials...
Loading clinical trials...
Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction - the ILO-HOPE Clinical Trial
Conditions
Interventions
Iloprost
Placebo
Locations
1
Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Start Date
November 29, 2017
Primary Completion Date
January 1, 2020
Completion Date
January 1, 2020
Last Updated
August 14, 2019
NCT03549559
NCT03269630
NCT06937320
NCT03387813
NCT03541603
NCT03184311
Lead Sponsor
National Taiwan University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions